Antibiotics Market 2024-2028: Size and Development of antibiotic-resistant strains; growth driven by the Product, Some of key Companies Positioned Strategically

The antibiotics market size by Product (Broad-spectrum antibiotics and Narrow-spectrum antibiotics), Route Of Administration (Intravenous, Oral, and Others), and Geography (Asia, North America, Europe, and Rest of World (ROW)), is forecast to increase by USD 16631.3 million. The market is expected to grow at a CAGR of  over 5.67% between 2024 and 2028.

• The emergence of multidrug-resistant microbes poses a significant challenge to the human health sector. This issue arises when microbes adapt to protect themselves against antimicrobial agents, resulting in antibiotic resistance. Irrational prescription and usage of antibiotics by both healthcare professionals and individuals, coupled with their excessive application in livestock and agriculture, contribute to the development of antibiotic-resistant strains. This phenomenon is primarily driven by the increased accumulation of antibiotics in organisms, leading to a substantial market demand for novel, effective antibiotics.
• The Antibiotics Market represents a significant business opportunity, driven by the increasing prevalence of bacterial infections and the resulting demand for effective antibiotic treatments. Key market trends include the development of novel antibiotics to combat antibiotic resistance, the growth of the generics segment, and the expanding use of antibiotics in animal health. Companies in this sector must navigate regulatory challenges and invest in research and development to stay competitive.

Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:

• Abbott Laboratories
• AbbVie Inc.
• Armata Pharmaceuticals Inc.
• Aspen Pharmacare Holdings Ltd.
• Astellas Pharma Inc.
• Aurobindo Pharma Ltd.
• Bayer AG
• F. Hoffmann La Roche Ltd.
• Flynn Pharma Ltd.
• GlaxoSmithKline Plc
• Incepta Pharmaceuticals Ltd.
• Johnson and Johnson Services Inc.
• Lupin Ltd.
• Mayne Pharma Group Ltd.
• Melinta Therapeutics LLC
• Merck KGaA
• Pfizer Inc.
• Sanofi SA
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/